Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclical immunotherapy in patients with psoriasis

P Amerio1, M Gravante, M Andreassi

  • 1Department of Dermatology, University of Chieti, Italy.

Acta Dermato-Venereologica. Supplementum
|January 1, 1994
PubMed
Summary

Cyclosporin A (CyA) offers effective low-dose treatment for psoriasis, achieving rapid remissions in 77% of plaque psoriasis cases. This approach enables personalized cyclical therapy with minimal side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atypical Spitz Tumor With RET::MXT1 Gene Rearrangement in a 14-Year-Old Girl: An Integrated Histopathologic, Immunohistochemical, and Molecular Diagnostic Approach.

Journal of cutaneous pathology·2026
Same author

Positioning of Melflufen in Heavily Pretreated RRMM Patients: Real-World Evidence in a Rapidly Evolving Therapeutic Landscape.

European journal of haematology·2026
Same author

A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide.

Clinical and experimental medicine·2025
Same author

Bispecific Antibodies and CAR T in Multiple Myeloma: Appropriate Selection of Patients and Sequencing.

Mediterranean journal of hematology and infectious diseases·2025
Same author

Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma.

Journal of bone oncology·2025
Same author

Gender differences in adult atopic dermatitis and clinical implication: Results from a nationwide multicentre study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Area of Science:

  • Immunodermatology
  • Pharmacology

Background:

  • Psoriasis is a chronic, unpredictable skin condition posing significant therapeutic challenges.
  • Advances in immunodermatology highlight new treatment strategies for psoriasis.

Purpose of the Study:

  • To evaluate the efficacy and safety of Cyclosporin A (CyA) in treating psoriasis.
  • To assess the benefits of low-dose and cyclical therapy with CyA.

Main Methods:

  • Clinical assessment of patient responses to low-dose Cyclosporin A (3-5 mg/kg/day).
  • Evaluation of Italian multi-center data on CyA tolerance and reliability.
  • Analysis of remission rates, duration, and side effect profiles.

Main Results:

  • Achieved rapid and effective remissions in psoriasis patients.

Related Experiment Videos

  • Demonstrated a 77% remission rate in plaque psoriasis cases.
  • Observed a paucity of side effects, supporting long-term use.

    • Conclusions:

    • Low-dose Cyclosporin A is an effective treatment for psoriasis.
    • Cyclical therapy with CyA allows for personalized treatment, dose optimization, and better side effect management.
    • CyA offers a reliable therapeutic option for managing chronic psoriasis.